Keywords: مهارکننده های 5α-ردوکتاز; Lower urinary tract symptoms; Combination therapy; 5α-Reductase inhibitors; α-Blockers; Phosphodiesterase-5-inhibitors; Antimuscarinics; SÃntomas del tracto urinario inferior; Terapia de combinación; Inhibidores de la 5α-reductasa; Bloqueadores alfa;
مقالات ISI مهارکننده های 5α-ردوکتاز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
Keywords: مهارکننده های 5α-ردوکتاز; Benign prostatic hyperplasia (BPH); 5α-Reductase inhibitors; Steroidal 3-carboxylic acids; Epristeride;
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition
Keywords: مهارکننده های 5α-ردوکتاز; 5α-Reductase inhibitors; Active surveillance; Chemoprevention; Dutasteride; Finasteride; NKX3.1; Precision cancer prevention; Prostate cancer;
In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles
Keywords: مهارکننده های 5α-ردوکتاز; liquid crystalline nanoparticles; chitosan; 5α-reductase inhibitors; skin distribution;
Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists
Keywords: مهارکننده های 5α-ردوکتاز; Prostate cancer; AR antagonists; 5α-Reductase inhibitors; Synthesis; Steroids;
Outcomes of Prostate Cancer Screening by 5α-Reductase Inhibitor Use
Keywords: مهارکننده های 5α-ردوکتاز; prostatic neoplasms; prostate-specific antigen; mass screening; 5α-reductase inhibitors; Finland; 5-ARI; 5α-reductase inhibitor; BPH; benign prostatic hyperplasia; DRE; digital rectal examination; FinRSPC; Finnish Randomized Study of Screening for Prost
Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials
Keywords: مهارکننده های 5α-ردوکتاز; Lower urinary tract symptoms; Benign prostatic hyperplasia; Phytotherapy; Serenoa repens; Permixon; α-Blockers; Tamsulosin; 5α-Reductase inhibitors; Finasteride; Erectile dysfunction; Randomized controlled trial; Systematic review; Meta-analysis;
Research paperSocioeconomic profile of elderly Polish men treated for benign prostate hyperplasia: Results of the population-based PolSenior study
Keywords: مهارکننده های 5α-ردوکتاز; Benign prostate hyperplasia; Pharmacotherapy; 5α-reductase inhibitors; α1-adrenergic antagonists; Epidemiology; 5αRI; 5α reductase inhibitor; ADL; activities of daily living; ARA; α1-adrenergic antagonist; BMI; Body Mass Index; BPH; benign prostate h
Development of a new gas chromatography-mass spectrometry (GC-MS) methodology for the evaluation of 5α-reductase activity
Keywords: مهارکننده های 5α-ردوکتاز; T; testosterone; DHT; dihydrotestosterone; BPH; benign prostate hyperplasia; 5α-R; 5α-reductase; AR; androgen receptor; RIs; 5α-reductase inhibitors; DLLME; dispersive liquid-liquid microextraction; GC-MS; gas chromatography-mass spectrometry; TL
5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
Keywords: مهارکننده های 5α-ردوکتاز; Steroid; Cyanopyridones; Cyanothiopyridones; 5α-Reductase inhibitors; Antiviral and anti-tumor activities;
Endocrine prevention and treatment of prostate cancer
Keywords: مهارکننده های 5α-ردوکتاز; 5α-Reductase inhibitors; GnRH agonists; GnRH antagonists; Antiandrogens; Oestrogens; Adverse effects;
An overview on 5α-reductase inhibitors
Keywords: مهارکننده های 5α-ردوکتاز; 5α-Reductase inhibitors; Androgens; Azasteroids; Testosterone; BPH; 5α-Dihydrotestosterone;
Treatment of Benign Prostatic Hyperplasia and Occurrence of Prostatic Surgery and Acute Urinary Retention: A Population-Based Cohort Study in The Netherlands
Keywords: مهارکننده های 5α-ردوکتاز; Benign prostatic hyperplasia; Cohort study; Database; 5α-reductase inhibitors; α-adrenoceptor antagonist;
New 5α-reductase inhibitors: In vitro and in vivo effects
Keywords: مهارکننده های 5α-ردوکتاز; 5α-Reductase; 5α-Reductase inhibitors; Prostate; Pregnadiene derivatives; In vivo effect of 5α-reductase inhibitors; Epoxide toxicity;
Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO)
Keywords: مهارکننده های 5α-ردوکتاز; Lower urinary tract symptoms; Benign prostatic obstruction; Nocturia; Nocturnal polyuria; Decreased bladder capacity; Quality of life; Bothersomeness; α1-adrenoceptor antagonists; 5α-reductase inhibitors;